← Evidence map

TrialClinical pharmacokinetics2020

An Open-Label, Single-Period, Two-Stage, Single Oral Dose Pharmacokinetic Study of Remogliflozin Etabonate Tablet 100 and 250 mg in Healthy Asian Indian Male Subjects Under Fasting and Fed Conditions.

Shashank Joshi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2020

this papercites it

An Open-Label, Single-Period, Two-Stage, Single Oral Dose Pharmacokinetic Study of Remogliflozin Etabonate Tablet 100 and 250 mg in Healthy Asian Indian Male Subjects Under Fasting and Fed Conditions. | Socratic